Findings

What do systematic reviews say?

124 questions · 127 findings · 17 reviews

No studies found 32 · 25.2%GRADE not reported 11 · 8.7%Very low 53 · 41.7%Low 18 · 14.2%Moderate 13 · 10.2%High 0 · 0%

Mental state: clinically important change in mental state · patients with schizophrenia

1 finding from 1 review

Chlorpromazine versus penfluridol for schizophrenia 2017 · Cochrane Headline outcomes only
no estimate extracted
0 studies · 0 participants
GRADE not reported

Adverse effect/event: clinically important extrapyramidal adverse events ‐ akathisia (medium term) · patients with schizophrenia

The intervention showed no clear difference in adverse effect/event: clinically important extrapyramidal adverse… (low certainty).

1 finding from 1 review

Chlorpromazine versus penfluridol for schizophrenia 2017 · Cochrane Headline outcomes only
RR 0.19 [0.04, 1.06]
2 studies · 85 participants
Low

Adverse effect/event: death · patients with schizophrenia

1 finding from 1 review

Chlorpromazine versus penfluridol for schizophrenia 2017 · Cochrane Headline outcomes only
no estimate extracted
0 studies · 2 participants
GRADE not reported

Leaving the study early: any reason (medium term) · patients with schizophrenia

The intervention showed no clear difference in leaving the study early: any reason (medium term) (low certainty).

1 finding from 1 review

Chlorpromazine versus penfluridol for schizophrenia 2017 · Cochrane Headline outcomes only
RR 1.21 [0.83, 1.77]
3 studies · 130 participants
Low